Literature DB >> 15886302

Eosinophil granulocytes are activated during the remission phase of ulcerative colitis.

M Lampinen1, A Rönnblom, K Amin, G Kristjansson, F Rorsman, P Sangfelt, B Säfsten, M Wagner, A Wanders, O Winqvist, M Carlson.   

Abstract

AIM: The aim of this study was to establish a method of investigating intestinal eosinophil and neutrophil granulocytes by flow cytometry, and to compare the distribution and activity of these cells in different stages of ulcerative colitis (UC).
METHODS: Biopsy samples were taken from six locations of the entire colon and from the terminal ileum in 10 patients with active total UC, 10 patients with inactive total UC, eight patients with active distal UC, and 11 control subjects. Cell suspensions from biopsies and from peripheral blood were incubated with fluorophore conjugated monoclonal antibodies. The use of scatter plot-gating and specific antibodies was established in a flow cytometry assay.
RESULTS: Eosinophils were more numerous and more active in patients with active UC than in controls. Interestingly, during inactive UC, the number of activated eosinophils was even larger. Eosinophil activity was high in the rectum of patients with distal colitis but was also slightly elevated in the proximal colon. Neutrophils were increased in number and activity during active but not inactive UC. In patients with distal colitis, activated neutrophils were only found in the sigmoid colon and rectum.
CONCLUSION: With this method, we confirm that neutrophils participate in the inflammatory process during active UC, and that they express a resting phenotype during remission. The finding of activated eosinophils in inflamed intestine strengthens the view of these cells as proinflammatory and tissue damaging. Nevertheless, our new finding of high eosinophil activation during inactive UC suggests that eosinophils play a role in repair of injured epithelium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886302      PMCID: PMC1774808          DOI: 10.1136/gut.2005.066423

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Retinoic acid modulates IL-5 receptor expression and selectively inhibits eosinophil-basophil differentiation of hemopoietic progenitor cells.

Authors:  John W Upham; Roma Sehmi; Lisa M Hayes; Karen Howie; Joachim Lundahl; Judah A Denburg
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

2.  Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.

Authors:  M Carlson; Y Raab; L Sevéus; S Xu; R Hällgren; P Venge
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  Activation of eosinophils in the pathophysiology of ulcerative colitis.

Authors:  K Makiyama; S Kanzaki; K Yamasaki; W Zea-Iriarte; Y Tsuji
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

4.  Intracellular and surface distribution of CD9 in human eosinophils.

Authors:  E Fernvik; G Halldén; J Hed; J Lundahl
Journal:  APMIS       Date:  1995-10       Impact factor: 3.205

5.  Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique.

Authors:  M Jeziorska; N Haboubi; P Schofield; D E Woolley
Journal:  J Pathol       Date:  2001-08       Impact factor: 7.996

6.  The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin.

Authors:  Simon Phipps; Sun Ying; Arun Wangoo; Yee-Ean Ong; Francesca Levi-Schaffer; A Barry Kay
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  Identification of interleukin-2 in human peripheral blood eosinophils.

Authors:  F Levi-Schaffer; J Barkans; T M Newman; S Ying; M Wakelin; R Hohenstein; V Barak; P Lacy; A B Kay; R Moqbel
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

8.  Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils.

Authors:  H Nakajima; G J Gleich; H Kita
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

9.  A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.

Authors:  Christer G B Peterson; Elisabeth Eklund; Yesuf Taha; Yngve Raab; Marie Carlson
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

10.  Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease.

Authors:  Ana Teresa Pugas Carvalho; Celeste Carvalho Siqueira Elia; Heitor Siffert Pereira de Souza; Paulo Roberto Pinheiro Elias; Eduardo Lopes Pontes; Hannah Pitanga Lukashok; Fernanda Cristina Dias de Freitas; José Roberto Lapa e Silva
Journal:  J Clin Gastroenterol       Date:  2003-02       Impact factor: 3.062

View more
  42 in total

1.  The role of eosinophils in inflammatory bowel disease.

Authors:  S Al-Haddad; R H Riddell
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

2.  CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.

Authors:  Maria Lampinen; Amanda Waddell; Richard Ahrens; Marie Carlson; Simon P Hogan
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

3.  The effect of sodium valproate on acetic acid-induced colitis in rats.

Authors:  Ali Najafi; Ehsan Motaghi; Mohammad Javad Hosseini; Masoumeh Ghasemi-Pirbaluti
Journal:  Inflammopharmacology       Date:  2016-12-31       Impact factor: 4.473

4.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

5.  IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.

Authors:  Carlo De Salvo; Xiao-Ming Wang; Luca Pastorelli; Benedetta Mattioli; Sara Omenetti; Kristine A Buela; Saleem Chowdhry; Rekha R Garg; Wendy A Goodman; Alex Rodriguez-Palacios; Dirk E Smith; Derek W Abbott; Fabio Cominelli; Giorgos Bamias; Wei Xin; James J Lee; Maurizio Vecchi; Theresa T Pizarro
Journal:  Am J Pathol       Date:  2016-02-22       Impact factor: 4.307

Review 6.  The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.

Authors:  K Jovanovic; M Siebeck; R Gropp
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

7.  CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling.

Authors:  Joanne C Masterson; Eóin N McNamee; Paul Jedlicka; Sophie Fillon; Joseph Ruybal; Lindsay Hosford; Jesús Rivera-Nieves; James J Lee; Glenn T Furuta
Journal:  Am J Pathol       Date:  2011-09-23       Impact factor: 4.307

8.  Classification of eosinophilic disorders of the small and large intestine.

Authors:  Aoife J McCarthy; Kieran Sheahan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

Review 9.  Functional role of eosinophils in gastrointestinal inflammation.

Authors:  Simon P Hogan
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

10.  Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis.

Authors:  Ariel Munitz; Amanda Waddell; Luqman Seidu; Eric T Cole; Richard Ahrens; Simon P Hogan; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2008-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.